beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms - PubMed (original) (raw)
Review
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms
D Porte Jr et al. Diabetes. 2001 Feb.
Abstract
Type 2 diabetes is characterized by a progressive loss of beta-cell function throughout the course of the disease. The pattern of loss is an initial defect in early or first-phase insulin secretion, followed by a decreasing maximal capacity of glucose to potentiate all nonglucose signals. Last, a defective steady-state and basal insulin secretion develops, leading to complete beta-cell failure requiring insulin treatment. This functional loss exceeds the expected impact of a 20-50% loss of beta-cells reported at autopsy, which has been associated with amyloid deposits. This review summarizes the nature of the amyloid deposition process and its association with disproportionate hyperproinsulinemia. It reviews recent studies in IAPP (islet-amyloid polypeptide, or amylin) transgenic mice developing islet amyloid deposits and hyperglycemia to suggest that the process of amyloid fibril formation impairs function early and leads to beta-cell failure and eventual death. Based on the known association of amyloid deposits and relative hyperproinsulinemia, it is hypothesized that fibril formation begins during impaired glucose tolerance after other factors cause the initial defects in early insulin secretion and insulin action. Thus, the process that leads to beta-cell loss is implicated in the deposition of amyloid and the late unrelenting progressive hyperglycemia now found in all patients despite current therapies.
Similar articles
- Banting lecture 1990. Beta-cells in type II diabetes mellitus.
Porte D Jr. Porte D Jr. Diabetes. 1991 Feb;40(2):166-80. doi: 10.2337/diab.40.2.166. Diabetes. 1991. PMID: 1991568 Review. - beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
Andrikopoulos S, Verchere CB, Terauchi Y, Kadowaki T, Kahn SE. Andrikopoulos S, et al. Diabetes. 2000 Dec;49(12):2056-62. doi: 10.2337/diabetes.49.12.2056. Diabetes. 2000. PMID: 11118007 - Islet amyloid polypeptide and type 2 diabetes.
Marzban L, Park K, Verchere CB. Marzban L, et al. Exp Gerontol. 2003 Apr;38(4):347-51. doi: 10.1016/s0531-5565(03)00004-4. Exp Gerontol. 2003. PMID: 12670620 Review. - Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.
Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE. Verchere CB, et al. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3492-6. doi: 10.1073/pnas.93.8.3492. Proc Natl Acad Sci U S A. 1996. PMID: 8622964 Free PMC article. - Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC. Janson J, et al. Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7283-8. doi: 10.1073/pnas.93.14.7283. Proc Natl Acad Sci U S A. 1996. PMID: 8692984 Free PMC article.
Cited by
- Molecular iodine-promoted oxidative cyclization for the synthesis of 1,3,4-thiadiazole-fused- [1,2,4]-thiadiazole incorporating 1,4-benzodioxine moiety as potent inhibitors of α-amylase and α-glucosidase: In vitro and in silico study.
Hussain R, Shah M, Iqbal S, Rehman W, Khan S, Rasheed L, Naz H, Al-Ghulikah HA, Elkaeed EB, Pashameah RA, Alzahrani E, Farouk AE. Hussain R, et al. Front Chem. 2022 Oct 6;10:1023316. doi: 10.3389/fchem.2022.1023316. eCollection 2022. Front Chem. 2022. PMID: 36339037 Free PMC article. - Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein.
Fleming A, Rosenberg L. Fleming A, et al. J Diabetes Sci Technol. 2007 Mar;1(2):231-44. doi: 10.1177/193229680700100214. J Diabetes Sci Technol. 2007. PMID: 19888412 Free PMC article. - Sex-specific Associations Between Type 2 Diabetes Incidence and Exposure to Dioxin and Dioxin-like Pollutants: A Meta-analysis.
Gang N, Van Allen K, Villeneuve PJ, MacDonald H, Bruin JE. Gang N, et al. Front Toxicol. 2022 Feb 23;3:685840. doi: 10.3389/ftox.2021.685840. eCollection 2021. Front Toxicol. 2022. PMID: 35295132 Free PMC article. Review. - Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes.
Ye R, Onodera T, Scherer PE. Ye R, et al. J Endocr Soc. 2019 Feb 4;3(3):617-631. doi: 10.1210/js.2018-00372. eCollection 2019 Mar 1. J Endocr Soc. 2019. PMID: 30834357 Free PMC article. Review. - Insulin regulates carboxypeptidase E by modulating translation initiation scaffolding protein eIF4G1 in pancreatic β cells.
Liew CW, Assmann A, Templin AT, Raum JC, Lipson KL, Rajan S, Qiang G, Hu J, Kawamori D, Lindberg I, Philipson LH, Sonenberg N, Goldfine AB, Stoffers DA, Mirmira RG, Urano F, Kulkarni RN. Liew CW, et al. Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2319-28. doi: 10.1073/pnas.1323066111. Epub 2014 May 19. Proc Natl Acad Sci U S A. 2014. PMID: 24843127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical